Wellbiotec Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported net loss was KRW 534.28 million compared to KRW 7,187.6 million a year ago. Basic loss per share from continuing operations was KRW 9 compared to KRW 165 a year ago. Diluted loss per share from continuing operations was KRW 9 compared to KRW 165 a year ago. Basic loss per share was KRW 9 compared to KRW 165 a year ago.
For the nine months, net loss was KRW 8,369.63 million compared to KRW 34,155.93 million a year ago. Basic loss per share from continuing operations was KRW 154 compared to KRW 790 a year ago. Diluted loss per share from continuing operations was KRW 154 compared to KRW 790 a year ago. Basic loss per share was KRW 154 compared to KRW 790 a year ago.